Concepedia

Yezi Wu

YW

Statistics

Publications

8

Citations

313

H-Index

8

Active since

2018

Affiliations

Shenzhen Third People’s Hospital(Current)

Southern University of Science and Technology

Guangzhou Medical University

Hubei University of Medicine

Anhui Medical University

Yezi Wu is an author at Shenzhen Third People’s Hospital specializing in cancer cell signaling, pharmacology, and oncology.

Publications per year

2018–2024

8

Publications

8

RETRACTED: Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis

Yunfei Zhang, Ping Huang, Xuewen Liu et al. · Journal of Pharmacological Sciences · 2018 · 70 citations · Full text

, , +17

Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2

Gang Xu, Yezi Wu, Tongyang Xiao et al. · Signal Transduction and Targeted Therapy · 2022 · 61 citations · Full text

, , +17

Polyphyllin I activates AMPK to suppress the growth of non-small-cell lung cancer via induction of autophagy

Yezi Wu, Yuan Si, Yuchen Xiang et al. · Archives of Biochemistry and Biophysics · 2020 · 51 citations · Full text

, , +17

Cucurbitacin B Inhibits the Hippo-YAP Signaling Pathway and Exerts Anticancer Activity in Colorectal Cancer Cells

Yanting Chai, Ke Xiang, Yezi Wu et al. · Medical Science Monitor · 2018 · 41 citations · Full text

, , +17

Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia

Wenjing Ma, Yuchen Xiang, Rui Yang et al. · Journal of Pharmacological Sciences · 2019 · 35 citations · Full text

, , +17

1–5 of 8